Keywords: gsk, posts, solid, results, 1st-qtr, eps, rise
GSK posts solid results for 1st-qtr 2007 with a 14% EPS rise despite US generic pressure
Article | 30 April 2007
UK drug major GlaxoSmithKline says that its first-quarter 2007 operating profit reached L2.17 billion ($4.3 million), up 11% on the like, year-ago period, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
